Wright MFM

Language: Spanish
References: 15
Page:
PDF size: 146.52 Kb.

ABSTRACT

Xeroderma pigmentosum is a rare autosomal recessive genodermatosis caused by a defect in nucleotide excision repair. The disease is characterized by increased skin sensitivity after minimal sun exposure. These patients are born with normal appearing skin but develop dermatological changes between the first and second year of life. Xerodermia pigmentosum presents with changes in skin pigmentation in a freckle-like distribution. In addition, patients will present with poikiloderma, xerosis, skin atrophy, lentigines, actinic keratosis and telangiectasias. The main complications of the disease are premalignant and malignant skin lesions. The most common cause of death is metastatic melanoma or invasive squamous cell carcinoma. Xeroderma pigmentosum is also associated with ophthalmological, neurodegenerative and endocrine disorders.
There is no curative treatment; management is based on early diagnosis of the disease through the detection of biallelic mutations and the implementation of early protective measures to reduce complications and mortality.

REFERENCES

1. Rizza ERH, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: A model for human premature aging. J Invest Dermatol [Internet]. 2021;141(4):976–84. DOI: http://dx.doi.org/10.1016/j.jid.2020.11.012

2. Piccione M, Belloni Fortina A, Ferri G, Andolina G, Beretta L, Cividini A, et al. Xeroderma Pigmentosum: General aspects and management. J Pers Med [Internet]. 2021;11(11):1146. DOI: http://dx.doi.org/10.3390/jpm11111146

3. Black JO. Xeroderma pigmentosum. Head Neck Pathol [Internet]. 2016;10(2):139–44. DOI: http://dx.doi.org/10.1007/s12105-016-0707-8

4. Brambullo T, Colonna MR, Vindigni V, Piaserico S, Masciopinto G, Galeano M, et al. Xeroderma pigmentosum: A genetic condition skin cancer correlated—A systematic review. Biomed Res Int [Internet]. 2022;2022:1–12. DOI: http://dx.doi.org/10.1155/2022/8549532

5. Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL. Xeroderma pigmentosum: an updated review. Drugs Context [Internet]. 2022;11:1–17. DOI: http://dx.doi.org/10.7573/dic.2022-2-5

6. Merideth M, Tamura D, Angra D, Khan SG, Ferrell J, Goldstein AM, et al. Reproductive health in xeroderma pigmentosum: Features of premature aging. Obstet Gynecol [Internet]. 2019;134(4):814–9. DOI: http://dx.doi.org/10.1097/aog.0000000000003490

7. Nasrallah NA, Wiese BM, Sears CR. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies. Front Oncol [Internet]. 2022;12. DOI: http://dx.doi.org/10.3389/fonc.2022.846965

8. Schierbeck J, Vestergaard T, Bygum A. Skin cancer associated genodermatoses: A literature review. Acta Derm Venereol [Internet]. 2019;99(4):360–9. DOI: http://dx.doi.org/10.2340/00015555-3123

9. Lehmann AR, Fassihi H. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum. DNA Repair (Amst) [Internet].2020;93(102907):102907. DOI: http://dx.doi.org/10.1016/j.dnarep.2020.102907

10. Abeti R, Zeitlberger A, Peelo C, Fassihi H, Sarkany RPE, Lehmann AR, et al. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. Br J Pharmacol [Internet]. 2019;176(22):4293–301. DOI: http://dx.doi.org/10.1111/bph.14557

11. De Andrade FAG, Cavalcanti CE de O, Isoldi FC, Ferreira LM. Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review. Indian J Dermatol Venereol Leprol [Internet]. 2021;87(176):176–89. DOI: http://dx.doi.org/10.25259/ijdvl_431_19

12. Baykal C, Atcı T, Yılmaz Z, Büyükbabani N. Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review. J Cutan Pathol [Internet]. 2021;48(7):884–95. DOI: http://dx.doi.org/10.1111/cup.13979

13. Fischer S, Hamed M, Emmert S, Wolkenhauer O, Fuellen G, Thiem A. The prognostic and predictive role of xeroderma pigmentosum gene expression in melanoma. Front Oncol [Internet]. 2022;12. DOI: http://dx.doi.org/10.3389/fonc.2022.810058

14. Nikolaev S, Yurchenko AA, Sarasin A. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts. Orphanet J Rare Dis [Internet]. 2022;17(1). DOI: http://dx.doi.org/10.1186/s13023-022-02203-1

15. Cazar Melo DC, Armas Vega ADC. Etiología más frecuente del cáncer oral en adultos jóvenes: una revisión de literatura [Internet]. 2022 [citado el 14 de julio, 2024]. DOI: http://dx.doi.org/10.36097/rsan.v0i52.2149